American College Of Rheumatology

While many of the forthcoming American College of Rheumatology guidelines for rheumatoid arthritis capture the reality of clinical practice, some recommendations are “puzzling,” according to a speaker at the ACR State-of-the-Art Clinical Symposium.

Working with minimal data and the pressure of the pandemic, the American College of Rheumatology put together guidelines for COVID-19 vaccination in individuals with rheumatic and autoimmune diseases.

Patients with non-life-threatening autoimmune and inflammatory rheumatic conditions should be vaccinated for COVID-19 as soon as possible regardless of disease activity or severity, according to new American College of Rheumatology guidance.

Although maintenance of certification has long been held as proof that physicians are staying current with changes in their field, the tide may be turning, as an increasing number of physicians do not view its requirements as relevant to their specialty.

Rheumatology patients with musculoskeletal, inflammatory and autoimmune diseases should be vaccinated for COVID-19, according to newly released recommendations from the American College of Rheumatology.

The American College of Rheumatology has urged CMS to reconsider its recent interim final rule that would establish a “most-favored nation” payment model for Medicare Part B drugs, arguing it would disrupt patient access to rheumatic care.

The American College of Rheumatology has praised CMS for approving “long awaited” updates to cognitive care reimbursements for Medicare, increasing the amount for evaluation and management services.

Rheumatology Milestones 2.0 provides a rheumatology-specific “enhanced evaluation tool” with a “learner-centered educational approach” that will be used by every rheumatology fellowship training program in the U.S., researchers noted.

The American College of Rheumatology and 60 other health care groups have signed a letter in support of legislation that would ensure evaluation and management rate increases under Medicare without payment cuts to providers during the COVID-19 pandemic.

Glucocorticoids should no longer be the “default” option for many patients with rheumatoid arthritis, according to authors of a new recommendation document presented at ACR Convergence 2020.